The Oncology Institute, Inc. (TOI)
NASDAQ: TOI · Real-Time Price · USD
4.770
-0.180 (-3.64%)
Jul 29, 2026, 4:00 PM EDT - Market closed
The Oncology Institute Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 545.76 | 502.73 | 393.41 | 324.24 | 252.48 | 203 | |
Revenue Growth | 35.37% | 27.79% | 21.33% | 28.42% | 24.37% | 8.26% |
Cost of Revenue | 463.72 | 426.29 | 339.42 | 264.67 | 200.39 | 162.16 |
Gross Profit | 82.04 | 76.44 | 54 | 59.57 | 52.09 | 40.85 |
Selling, General & Admin | 108.19 | 105.57 | 107.83 | 113.85 | 119.69 | 83.37 |
Depreciation & Amortization Expenses | 6.77 | 6.94 | 6.29 | 5.87 | 4.41 | 3.34 |
Other Operating Expenses | - | - | - | 16.87 | 9.94 | - |
Total Operating Expenses | 114.97 | 112.52 | 114.12 | 136.59 | 134.04 | 86.71 |
Operating Income | -32.69 | -36.08 | -60.12 | -77.02 | -81.95 | -45.86 |
Interest Expense | -7.64 | -11.28 | -7.5 | -6.78 | -4.08 | -0.32 |
Other Non-Operating Income (Expense) | -3.32 | -13.38 | 2.95 | 0.69 | 85.94 | 34.58 |
Total Non-Operating Income (Expense) | -10.96 | -24.65 | -4.55 | -6.09 | 81.86 | 34.26 |
Pretax Income | -43.64 | -60.74 | -64.66 | -83.1 | -0.09 | -11.6 |
Provision for Income Taxes | -0.13 | 0.13 | - | 0.04 | -0.24 | 0.67 |
Net Income | -43.51 | -60.61 | -64.66 | -83.07 | 0.15 | -10.93 |
Net Income to Common | -36.28 | -50.31 | -53.01 | -67.88 | 0.07 | -10.63 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 98 | 92 | 75 | 74 | 73 | 66 |
Shares Outstanding (Diluted) | 98 | 92 | 75 | 74 | 81 | 66 |
Shares Change | 30.00% | 23.11% | 1.76% | -8.51% | 21.70% | 12.03% |
EPS (Basic) | -0.37 | -0.54 | -0.71 | -0.92 | - | -0.16 |
EPS (Diluted) | -0.37 | -0.54 | -0.71 | -0.92 | -0.21 | -0.16 |
EPS Growth | - | - | - | - | - | - |
Free Cash Flow | -25.73 | -27.79 | -30.33 | -40.88 | -67.29 | -35.53 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Per Share | -0.26 | -0.30 | -0.40 | -0.55 | -0.83 | -0.54 |
Gross Margin | 15.03% | 15.20% | 13.73% | 18.37% | 20.63% | 20.12% |
Operating Margin | -5.99% | -7.18% | -15.28% | -23.75% | -32.46% | -22.59% |
Profit Margin | -7.97% | -12.06% | -16.44% | -25.62% | 0.06% | -5.38% |
FCF Margin | -4.71% | -5.53% | -7.71% | -12.61% | -26.65% | -17.50% |
EBITDA | -25.91 | -29.14 | -53.83 | -71.15 | -77.54 | -42.52 |
EBITDA Margin | -4.75% | -5.80% | -13.68% | -21.94% | -30.71% | -20.94% |
EBIT | -32.69 | -36.08 | -60.12 | -77.02 | -81.95 | -45.86 |
EBIT Margin | -5.99% | -7.18% | -15.28% | -23.75% | -32.46% | -22.59% |
Effective Tax Rate | 0.30% | -0.22% | 0.00% | -0.04% | 267.03% | -5.79% |